Loading...
The Efficacy of Add-on Telbivudine Versus Switching to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients With Poor Responses to Adefovir
BACKGROUND: There are limited options for chronic hepatitis B (CHB) patients who have poor responses to adefovir (ADV). OBJECTIVES: The aim of this study is to evaluate the effects of adding on telbivudine (LdT) or switching to pegylated interferon alfa-2a (PEG-IFN-α2a) as alternative rescue therapi...
Na minha lista:
| Udgivet i: | Hepat Mon |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Kowsar
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4834190/ https://ncbi.nlm.nih.gov/pubmed/27110255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.31278 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|